The Master Survival Switch: PI3K-mTOR in Cancer
If a cell is starving, the mTOR pathway forces it into hibernation; if a cell has abundant nutrients, mTOR forces it to rapidly divide. In cancer, the tumor mutates the PI3K-mTOR pathway so the switch is permanently taped in the “divide” position, even when the cell is suffocating. PI3K-mTOR in Cancer and Cancer Therapy is a fiercely advanced, highly specialized molecular biology manual detailing exactly how to break this jammed switch. This volume provides the precise pharmacological blueprints for starving the tumor at a cellular level.
Mastering the Kinase Cascade
The core philosophy of this text is intercepting the signal. The authors aggressively detail the mechanics of the PI3K/AKT/mTOR axis. It dictates exactly how a mutation in the PIK3CA gene creates a continuous, false signal that tells the cell it has infinite glucose, driving explosive tumor growth, and exactly how specific inhibitors (like everolimus or alpelisib) chemically block this false signal.
Navigating the Feedback Loop
The book provides a masterclass in tumor adaptation. It dictates the exact molecular pathways of resistance. It rigorously explores the maddening reality that if you block mTOR, the cancer cell will often sense the blockade and violently upregulate AKT in response, creating a lethal feedback loop that forces the oncologist to design highly toxic, dual-inhibitor drug cocktails to trap the cell.
Frequently Asked Questions (FAQs)
Is this a clinical manual detailing standard chemotherapy like taxol?
No, it is a highly advanced *molecular pharmacology and targeted drug development textbook* focused entirely on the specific inhibitors of the PI3K-mTOR pathway.
Who is the primary audience?
It is the absolute, mandatory benchtop reference for Molecular Pharmacologists, Cancer Biologists, Drug Development Scientists, and Medical Oncologists.
